Catalog #SIM0093

InVivoSIM anti-human IL1RAP (IL-1R3) (Nadunolimab biosimilar)

Clone Nadunolimab
Reactivities Human
Isotype Human IgG1, κ

$243.00 - $8,425.00

$243.00 - $8.00

Choose an Option...
  • 100 mg - $8,425.00
  • 50 mg - $4,734.00
  • 25 mg - $3,293.50
  • 5 mg - $943.00
  • 1 mg - $243.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Description

This non-therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody Nadunolimab, making it ideal for research use. Nadunolimab is a fully human IgG1 monoclonal antibody that targets the interleukin-1 receptor accessory protein (IL1RAP), a co-receptor required for signaling through IL-1 family cytokine receptors including IL-1R1, IL-1R2, IL-33R (ST2), and IL-36 receptors. IL1RAP is overexpressed on a wide range of tumor types, including non-small cell lung cancer (NSCLC), pancreatic ductal adenocarcinoma (PDAC), and several hematologic malignancies, but is expressed at limited levels in normal tissues, making it an attractive therapeutic target. By binding IL1RAP, Nadunolimab blocks downstream IL-1 family signaling, which reduces tumor-promoting inflammation, inhibits NF-κB activation, and diminishes secretion of pro-tumor cytokines. In addition, Nadunolimab’s IgG1 Fc region enables potent antibody-dependent cell-mediated cytotoxicity (ADCC), facilitating direct killing of IL1RAP-expressing tumor cells. Nadunolimab has shown promising clinical activity in solid tumors particularly in combination with chemotherapy by modulating the inflammatory tumor microenvironment and promoting immune-mediated tumor clearance. This Nadunolimab biosimilar is well suited for studying IL-1 family receptor biology, tumor-associated inflammation, IL1RAP-dependent signaling, myeloid-driven immunosuppression, and therapeutic strategies targeting IL1RAP-expressing cancers.

Specifications

Isotype Human IgG1, κ
Recommended Isotype Control(s) RecombiMAb human IgG1 isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Immunogen Human IL1RAP
Reported Applications in vivo functional assays
in vitro functional assays
ELISA
Flow cytometry
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein A
Molecular Weight 150 kDa
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs